The tower will bring together some of the world’s top researchers. These experts are working to cure some of the world’s most prevalent chronic diseases – including Alzheimer’s, stroke, vision loss and arthritis.
The new nine-storey building, a $174-million endeavour, has four floors dedicated to University Health Network research space, in addition to one floor for the University of Toronto’s Tanz Centre for Research in Neurodegenerative Diseases.
There’s also an additional 1.5 floors dedicated to Altum Health, a UHN enterprise that provides unique solutions for injured workers and clients.
The Krembil Discovery Tower will foster research in neural and visual sciences, musculoskeletal disease and illnesses and disorders such as spinal cord injury, Parkinson’s disease, epilepsy, Alzheimer’s disease, arthritis and age-related blindness.
‘Best and brightest’
“Recruitment for the best researchers is very competitive in North America. In order to retain the brightest and best researchers, as well as recruit others, we have created a space that matches their calibre of work,” said UHN President and CEO, Dr. Bob Bell.
One such internationally renowned recruit is Dr. Donald Weaver, Director of the Toronto Western Research Institute.
A rarity among researchers worldwide, Weaver is currently the only qualified person in Canada to be a practicing neurologist with a PhD in medicinal chemistry and drug design.
Weaver’s pioneering platforms for drug discovery have earned him prestigious international awards, patents and a number of biotech companies.
To view the
PRESS RELEASE, click
here.
Related
